Alnylam and Takeda Form RNAi Partnership

By Helen Scrutton

Pharma Deals Review: Vol 2008 Issue 96 (Table of Contents)

Published: 27 May-2008

DOI: 10.3833/pdr.v2008.i96.172     ISSN: 1756-7874

Section: Research & Development

Fulltext:

Abstract

Japanese company, Takeda Pharmaceutical, has strengthened it oncology pipeline through this RNAi alliance with US biotech, Alnylam Pharmaceuticals...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details